Does gonadotropin-releasing-hormone agonist therapy for prostate cancer increase the risk of fracture?
Publication
, Journal Article
Armstrong, AJ; Eisenberger, M
Published in: Nat Clin Pract Urol
May 2006
Duke Scholars
Published In
Nat Clin Pract Urol
DOI
ISSN
1743-4270
Publication Date
May 2006
Volume
3
Issue
5
Start / End Page
246 / 247
Location
United States
Related Subject Headings
- Urology & Nephrology
- 3202 Clinical sciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Armstrong, A. J., & Eisenberger, M. (2006). Does gonadotropin-releasing-hormone agonist therapy for prostate cancer increase the risk of fracture? Nat Clin Pract Urol, 3(5), 246–247. https://doi.org/10.1038/ncpuro0462
Armstrong, Andrew J., and Mario Eisenberger. “Does gonadotropin-releasing-hormone agonist therapy for prostate cancer increase the risk of fracture?” Nat Clin Pract Urol 3, no. 5 (May 2006): 246–47. https://doi.org/10.1038/ncpuro0462.
Armstrong AJ, Eisenberger M. Does gonadotropin-releasing-hormone agonist therapy for prostate cancer increase the risk of fracture? Nat Clin Pract Urol. 2006 May;3(5):246–7.
Armstrong, Andrew J., and Mario Eisenberger. “Does gonadotropin-releasing-hormone agonist therapy for prostate cancer increase the risk of fracture?” Nat Clin Pract Urol, vol. 3, no. 5, May 2006, pp. 246–47. Pubmed, doi:10.1038/ncpuro0462.
Armstrong AJ, Eisenberger M. Does gonadotropin-releasing-hormone agonist therapy for prostate cancer increase the risk of fracture? Nat Clin Pract Urol. 2006 May;3(5):246–247.
Published In
Nat Clin Pract Urol
DOI
ISSN
1743-4270
Publication Date
May 2006
Volume
3
Issue
5
Start / End Page
246 / 247
Location
United States
Related Subject Headings
- Urology & Nephrology
- 3202 Clinical sciences
- 1103 Clinical Sciences